News China strives to lower cost of cancer drugs as disease rates... China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
